MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma

NCT01333475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: MK-2206 + AZD6244

Sponsor

National Cancer Institute (NCI)